Literature DB >> 28339747

Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts.

Anne Cocos1, Alexander G Fiks1, Aaron J Masino1.   

Abstract

OBJECTIVE: Social media is an important pharmacovigilance data source for adverse drug reaction (ADR) identification. Human review of social media data is infeasible due to data quantity, thus natural language processing techniques are necessary. Social media includes informal vocabulary and irregular grammar, which challenge natural language processing methods. Our objective is to develop a scalable, deep-learning approach that exceeds state-of-the-art ADR detection performance in social media.
MATERIALS AND METHODS: We developed a recurrent neural network (RNN) model that labels words in an input sequence with ADR membership tags. The only input features are word-embedding vectors, which can be formed through task-independent pretraining or during ADR detection training.
RESULTS: Our best-performing RNN model used pretrained word embeddings created from a large, non-domain-specific Twitter dataset. It achieved an approximate match F-measure of 0.755 for ADR identification on the dataset, compared to 0.631 for a baseline lexicon system and 0.65 for the state-of-the-art conditional random field model. Feature analysis indicated that semantic information in pretrained word embeddings boosted sensitivity and, combined with contextual awareness captured in the RNN, precision. DISCUSSION: Our model required no task-specific feature engineering, suggesting generalizability to additional sequence-labeling tasks. Learning curve analysis showed that our model reached optimal performance with fewer training examples than the other models.
CONCLUSION: ADR detection performance in social media is significantly improved by using a contextually aware model and word embeddings formed from large, unlabeled datasets. The approach reduces manual data-labeling requirements and is scalable to large social media datasets.
© The Author 2017. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  Twitter messaging; adverse drug reaction; natural language processing; neural networks (computer); social media

Mesh:

Year:  2017        PMID: 28339747      PMCID: PMC7651964          DOI: 10.1093/jamia/ocw180

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  22 in total

1.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

2.  Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.

Authors:  Xiaoyan Wang; George Hripcsak; Marianthi Markatou; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2009-03-04       Impact factor: 4.497

3.  Long short-term memory.

Authors:  S Hochreiter; J Schmidhuber
Journal:  Neural Comput       Date:  1997-11-15       Impact factor: 2.026

4.  Identifying potential adverse effects using the web: a new approach to medical hypothesis generation.

Authors:  Adrian Benton; Lyle Ungar; Shawndra Hill; Sean Hennessy; Jun Mao; Annie Chung; Charles E Leonard; John H Holmes
Journal:  J Biomed Inform       Date:  2011-07-26       Impact factor: 6.317

5.  Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.

Authors:  Stephanie J Reisinger; Patrick B Ryan; Donald J O'Hara; Gregory E Powell; Jeffery L Painter; Edward N Pattishall; Jonathan A Morris
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

6.  Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis.

Authors:  Katja M Hakkarainen; Khadidja Hedna; Max Petzold; Staffan Hägg
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

7.  Various criteria in the evaluation of biomedical named entity recognition.

Authors:  Richard Tzong-Han Tsai; Shih-Hung Wu; Wen-Chi Chou; Yu-Chun Lin; Ding He; Jieh Hsiang; Ting-Yi Sung; Wen-Lian Hsu
Journal:  BMC Bioinformatics       Date:  2006-02-24       Impact factor: 3.169

8.  Adverse drug reactions of spontaneous reports in Shanghai pediatric population.

Authors:  Hui Li; Xiao-Jing Guo; Xiao-Fei Ye; Hong Jiang; Wen-Min Du; Jin-Fang Xu; Xin-Ji Zhang; Jia He
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

Review 9.  Clinical and economic burden of adverse drug reactions.

Authors:  Janet Sultana; Paola Cutroneo; Gianluca Trifirò
Journal:  J Pharmacol Pharmacother       Date:  2013-12

10.  Analysis of the effect of sentiment analysis on extracting adverse drug reactions from tweets and forum posts.

Authors:  Ioannis Korkontzelos; Azadeh Nikfarjam; Matthew Shardlow; Abeed Sarker; Sophia Ananiadou; Graciela H Gonzalez
Journal:  J Biomed Inform       Date:  2016-06-27       Impact factor: 6.317

View more
  41 in total

1.  Reply to comment on: "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts".

Authors:  Anne Cocos; Alexander G Fiks; Aaron J Masino
Journal:  J Am Med Inform Assoc       Date:  2019-06-01       Impact factor: 4.497

2.  Leveraging digital media data for pharmacovigilance.

Authors:  Hammad Farooq; Junaid Suhail Niaz; Saira Fakhar; Hammad Naveed
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

3.  Development of an automated phenotyping algorithm for hepatorenal syndrome.

Authors:  Jejo D Koola; Sharon E Davis; Omar Al-Nimri; Sharidan K Parr; Daniel Fabbri; Bradley A Malin; Samuel B Ho; Michael E Matheny
Journal:  J Biomed Inform       Date:  2018-03-09       Impact factor: 6.317

4.  Using deep learning to improve medication safety: the untapped potential of social media.

Authors:  Jiaheng Xie; Daniel Dajun Zeng; Zachary A Marcum
Journal:  Ther Adv Drug Saf       Date:  2017-09-06

5.  Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Arlene E Chung; Kimberly Shoenbill; Sandra A Mitchell; Amylou C Dueck; Deborah Schrag; Deborah W Bruner; Lori M Minasian; Diane St Germain; Ann M O'Mara; Paul Baumgartner; Lauren J Rogak; Amy P Abernethy; Ashley C Griffin; Ethan M Basch
Journal:  J Am Med Inform Assoc       Date:  2019-04-01       Impact factor: 4.497

6.  A systematic review of natural language processing and text mining of symptoms from electronic patient-authored text data.

Authors:  Caitlin Dreisbach; Theresa A Koleck; Philip E Bourne; Suzanne Bakken
Journal:  Int J Med Inform       Date:  2019-02-20       Impact factor: 4.046

7.  Detecting Adverse Drug Reactions on Twitter with Convolutional Neural Networks and Word Embedding Features.

Authors:  Aaron J Masino; Daniel Forsyth; Alexander G Fiks
Journal:  J Healthc Inform Res       Date:  2018-04-12

8.  Artificial Intelligent Context-Aware Machine-Learning Tool to Detect Adverse Drug Events from Social Media Platforms.

Authors:  Don Roosan; Anandi V Law; Moom R Roosan; Yan Li
Journal:  J Med Toxicol       Date:  2022-09-12

Review 9.  Clinical concept extraction: A methodology review.

Authors:  Sunyang Fu; David Chen; Huan He; Sijia Liu; Sungrim Moon; Kevin J Peterson; Feichen Shen; Liwei Wang; Yanshan Wang; Andrew Wen; Yiqing Zhao; Sunghwan Sohn; Hongfang Liu
Journal:  J Biomed Inform       Date:  2020-08-06       Impact factor: 6.317

Review 10.  Artificial Intelligence for Drug Toxicity and Safety.

Authors:  Anna O Basile; Alexandre Yahi; Nicholas P Tatonetti
Journal:  Trends Pharmacol Sci       Date:  2019-08-02       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.